Inozyme Pharma

Inozyme Pharma

Biotechnology, 321 Summer St, Boston, Massachusetts, 02210, United States, 11-50 Employees

inozyme.com

  • facebook
  • twitter
  • LinkedIn

phone no Phone Number: 85********

Who is INOZYME PHARMA

We are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement the...

Read More

map
  • 321 Summer St, Boston, Massachusetts, 02210, United States Headquarters: 321 Summer St, Boston, Massachusetts, 02210, United States
  • 2016 Date Founded: 2016
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: $25 Million to $50 Million
  • tech-icon Active Tech Stack: See technologies
  • Doug Treco CEO:   Doug Treco

industries-icon Industry: Biotechnology

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from INOZYME PHARMA

Inozyme Pharma Org Chart and Mapping

VP-Level

Kurt Gunter

SVP and Chief Medical Officer

Employees

Karen Berry

Associate Director Clinical Operations

Yves Sabbagh

Chief Scientific Officer

Leontia Burke

Vice President Clinical Operations

Sophia Bessette

Senior Quality Assurance Manager

Daniel Ortiz

Senior Director of Research

Shanthini Jeyarajah

Senior Director, Analytical Development and Quality Control

Sebastian Torres

Senior Director of Drug Product

Hannah Crowell

Corporate Office Administrator

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Inozyme Pharma

Answer: Inozyme Pharma's headquarters are located at 321 Summer St, Boston, Massachusetts, 02210, United States

Answer: Inozyme Pharma's phone number is 85********

Answer: Inozyme Pharma's official website is https://inozyme.com

Answer: Inozyme Pharma's revenue is $25 Million to $50 Million

Answer: Inozyme Pharma's SIC: 2834

Answer: Inozyme Pharma has 11-50 employees

Answer: Inozyme Pharma is in Biotechnology

Answer: Inozyme Pharma contact info: Phone number: 85******** Website: https://inozyme.com

Answer: We are a biopharmaceutical company specializing in the development of novel therapeutics to treat rare metabolic diseases. Our lead product candidate is INZ-701, an enzyme replacement therapy (ERT) in the early stages of clinical development for the potential treatment of patients with a variety of calcification disorders linked primarily to mutations in the ENPP1 and ABCC6 genes, or ENPP1 Deficiency and ABCC6 Deficiency respectively. We have demonstrated proof of concept with INZ-701 in both GACI and ARHR2 two phenotypes of ENPP1 Deficiency.

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access